{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:31:18Z","timestamp":1792647078766,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/mpa.0b013e31818815f7","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T12:24:03Z","timestamp":1234959843000},"page":"161-167","source":"Crossref","is-referenced-by-count":21,"title":["Liver Perfusion Chemotherapy With 5-Fluorouracil Followed by Systemic Gemcitabine Administration for Resected Pancreatic Cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"Isao","family":"Kurosaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kawachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koei","family":"Nihei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Aono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2-4","article-title":"An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging.","volume":"72","author":"Kayahara","year":"1993","journal-title":"Cancer"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6","article-title":"Patterns of failure after curative resection of pancreatic carcinoma.","volume":"66","author":"Griffin","year":"1990","journal-title":"Cancer"},{"key":"R3-10-20210212","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02788531","article-title":"The time of occurrence of liver metastasis in carcinoma of the pancreas.","volume":"17","author":"Amikura","year":"1995","journal-title":"Int J Pancreatol"},{"key":"R4-10-20210212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","article-title":"Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings.","volume":"10","author":"Hishinuma","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"R5-10-20210212","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0002-9610(05)80167-9","article-title":"Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas.","volume":"168","author":"Ishikawa","year":"1994","journal-title":"Am J Surg"},{"key":"R6-10-20210212","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s002689900604","article-title":"Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis.","volume":"23","author":"Beger","year":"1999","journal-title":"World J Surg"},{"key":"R7-10-20210212","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00280-006-0200-2","article-title":"Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.","volume":"58","author":"Cantore","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"R8-10-20210212","first-page":"831","article-title":"Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.","volume":"23","author":"Papachristou","year":"2003","journal-title":"Anticancer Res"},{"key":"R9-10-20210212","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1245\/s10434-006-9110-0","article-title":"Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer.","volume":"14","author":"Hayashibe","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R10-10-20210212","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00006676-200211000-00008","article-title":"Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection.","volume":"25","author":"Yamaue","year":"2002","journal-title":"Pancreas"},{"key":"R11-10-20210212","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/00000658-200212000-00013","article-title":"Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.","volume":"236","author":"Lygidakis","year":"2002","journal-title":"Ann Surg"},{"key":"R12-10-20210212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a010600","article-title":"A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.","volume":"7","author":"Rothenberg","year":"1996","journal-title":"Ann Oncol"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.ijrobp.2004.01.015","article-title":"Adjuvant therapy in pancreatic cancer: phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.","volume":"59","author":"Allen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-10-20210212","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0360-3016(03)00164-0","article-title":"Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.","volume":"56","author":"Van Laethem","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ijrobp.2003.07.002","article-title":"Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma.","volume":"58","author":"Wilkowski","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-10-20210212","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ijrobp.2005.01.043","article-title":"Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian phase II study.","volume":"62","author":"Demols","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-10-20210212","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000088952","article-title":"Adjuvant systemic chemotherapy with gemcitabine for stage IV pancreatic cancer: a preliminary report of initial experience.","volume":"51","author":"Kurosaki","year":"2005","journal-title":"Chemotherapy"},{"key":"R19-10-20210212","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(05)80349-1","article-title":"Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicenter study.","volume":"5","author":"Bakkevold","year":"1993","journal-title":"Eur J Cancer"},{"key":"R20-10-20210212","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF00294750","article-title":"Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations.","volume":"19","author":"Takahashi","year":"1995","journal-title":"World J Surg"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.sla.0000143300.49878.51","article-title":"Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer.","volume":"240","author":"Nakayama","year":"2004","journal-title":"Ann Surg"},{"key":"R24-10-20210212","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/bjs.1800661202","article-title":"Adjuvant cytotoxic liver perfusion for colorectal cancer.","volume":"66","author":"Taylor","year":"1979","journal-title":"Br J Surg"},{"key":"R25-10-20210212","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1245\/ASO.2005.05.028","article-title":"Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head.","volume":"12","author":"Ohigashi","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R26-10-20210212","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1046\/j.1365-2168.1999.01168.x","article-title":"Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.","volume":"86","author":"Ambiru","year":"1999","journal-title":"Br J Surg"},{"key":"R27-10-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0002-9610(05)81228-0","article-title":"Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases.","volume":"159","author":"Archer","year":"1990","journal-title":"Am J Surg"},{"key":"R28-10-20210212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(87)80078-8","article-title":"Angioarchitecture and blood supply of micro- and macrometastases in human livers. An anatomic-pathological investigation using injection-techniques.","volume":"4","author":"Strohmeyer","year":"1987","journal-title":"J Hepatol"},{"key":"R29-10-20210212","first-page":"589","article-title":"The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth.","volume":"75","author":"Ackerman","year":"1974","journal-title":"Surgery"},{"key":"R30-10-20210212","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10147-004-0393-5","article-title":"Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer.","volume":"9","author":"Onoue","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"R31-10-20210212","first-page":"5528","article-title":"Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells.","volume":"48","author":"Kotasek","year":"1988","journal-title":"Cancer Res"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2362.1987.tb01225.x","article-title":"Production of 5-lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease).","volume":"17","author":"Rondeau","year":"1987","journal-title":"Eur J Clin Invest"},{"key":"R33-10-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0002-9343(97)00272-6","article-title":"Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment.","volume":"103","author":"Amoura","year":"1997","journal-title":"Am J Med"},{"key":"R34-10-20210212","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-130-11-199906010-00015","article-title":"Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series.","volume":"130","author":"Tahirkheli","year":"1999","journal-title":"Ann Intern Med"},{"key":"R35-10-20210212","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ssu.2980050604","article-title":"Overview of interleukin-2 as an immunotherapeutic agent.","volume":"5","author":"Chang","year":"1989","journal-title":"Semin Surg Oncol"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment.","volume":"16","author":"Semb","year":"1998","journal-title":"J Clin Oncol"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00277-004-0946-8","article-title":"Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements.","volume":"84","author":"Deeren","year":"2005","journal-title":"Ann Hematol"},{"key":"R38-10-20210212","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1023\/A:1013163831194","article-title":"Gemcitabine-induced systemic capillary leak syndrome.","volume":"12","author":"De Pas","year":"2001","journal-title":"Ann Oncol"},{"key":"R39-10-20210212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1179\/joc.2003.15.3.287","article-title":"Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report.","volume":"15","author":"Pulkkanen","year":"2003","journal-title":"J Chemother"},{"key":"R40-10-20210212","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.clon.2004.06.019","article-title":"Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.","volume":"16","author":"Biswas","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R41-10-20210212","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clon.2005.09.003","article-title":"Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.","volume":"18","author":"Baron","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R42-10-20210212","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000658-199810000-00007","article-title":"Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.","volume":"228","author":"Pedrazzoli","year":"1998","journal-title":"Ann Surg"},{"key":"R43-10-20210212","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/bjs.4761","article-title":"Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status.","volume":"91","author":"Connor","year":"2004","journal-title":"Br J Surg"},{"key":"R44-10-20210212","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.surg.2005.02.009","article-title":"Para-aortic lymph node metastasis in carcinoma of the head of the pancreas.","volume":"137","author":"Sakai","year":"2005","journal-title":"Surgery"},{"key":"R45-10-20210212","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1245\/s10434-006-9131-8","article-title":"Pancreatic resection for M1 pancreatic ductal adenocarcinoma.","volume":"14","author":"Shrikhande","year":"2007","journal-title":"Ann Surg Oncol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0b013e31818815f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:30:12Z","timestamp":1633134612000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-200903000-00010"}},"subtitle":["Preliminary Results of a Prospective Phase 2 Study"],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e31818815f7","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}